<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05063006</url>
  </required_header>
  <id_info>
    <org_study_id>NB.0710.003.2021P</org_study_id>
    <nct_id>NCT05063006</nct_id>
  </id_info>
  <brief_title>Exercise Tolerance in Patients With Implanted Left Ventricular Assist Device</brief_title>
  <official_title>Exercise Tolerance in Patients With Implanted Left Ventricular Assist Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karol Wierzbicki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cor Aegrum Foundation of Cardiac Surgery Development in Cracow, Poland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medtronic Poland Spółka z ograniczoną odpowiedzialnością</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>AGH University of Science and Technology, Krakow, Poland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>John Paul II Hospital, Krakow</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the concept of dynamic pump speed optimization based on the echocardiographic&#xD;
      assessment of aortic valve opening during cardiopulmonary exercise test.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Left ventricular assist devices (LVAD) are becoming a destination therapy in patients with&#xD;
      end-stage left ventricular dysfunction. Current generation pumps operate with a fixed&#xD;
      rotation speed without the capability of automated speed adjustment. It was shown that&#xD;
      acceleration of the pump speed during stress test increases the maximum exercise tolerance.&#xD;
      Periodic aortic valve opening (AVO) is used to set up an optimal resting pump speed. The&#xD;
      study aimed to evaluate the concept of dynamic pump speed optimization based on the&#xD;
      echocardiographic assessment of AVO during the cardiopulmonary exercise test (CPET).&#xD;
&#xD;
      Patients with implanted third-generation LVADs with hydrodynamic bearing (HVAD, Medtronic,&#xD;
      MN, USA) are prospectively enrolled. Two CPETs are performed after resting speed&#xD;
      optimization. The first one with maintained baseline pump speed settings, and the second one&#xD;
      with gradually increased speed depending on live echocardiographic imaging. The sequence of&#xD;
      tests is random.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2017</start_date>
  <completion_date type="Actual">August 4, 2020</completion_date>
  <primary_completion_date type="Actual">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>prospective crossover AB/BA study</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Echocardiographic appraisal of aortic valve opening during cycle ergometer exercise.</measure>
    <time_frame>Immediately, during cycle ergometer exercise</time_frame>
    <description>Assessment of aortic valve opening during cycle ergometer exercise in LVAD patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in oxygen consumption</measure>
    <time_frame>Immediately, during cycle ergometer exercise</time_frame>
    <description>By using the cardiopulmonary exercise test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in perceived exertion</measure>
    <time_frame>Immediately, during cycle ergometer exercise</time_frame>
    <description>By using the Borg rating of perceived exertion scale. Score 6-20 (6 - no exertion, 20 - maximal exertion)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pump speed</measure>
    <time_frame>Immediately, during cycle ergometer exercise.</time_frame>
    <description>By assessing pump speed (RPM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pump flow</measure>
    <time_frame>Immediately, during cycle ergometer exercise</time_frame>
    <description>By assessing pump flow (l/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pump power</measure>
    <time_frame>Immediately, during cycle ergometer exercise</time_frame>
    <description>By assessing pump power (W)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Left Ventricular Assist Device</condition>
  <arm_group>
    <arm_group_label>LVAD pump speed dynamically adjusted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>LVAD pump at optimal resting speed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiopulmonary exercise tests with maintained baseline optimal pump speed settings.</intervention_name>
    <description>Optimal resting LVAD speed settings is defined as periodic aortic valve opening while maintaining the central position of the intraventricular septum, minimizing mitral regurgitation, and preserving the mean systemic blood pressure above 65 mmHg. The aim is to achieve an aortic valve opening ratio of around 25-33% by changing the pump speed at resting conditions.</description>
    <arm_group_label>LVAD pump at optimal resting speed</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiopulmonary exercise test with gradually increased pump speed depending on live echocardiographic imaging.</intervention_name>
    <description>During the modified speed exercise, when the aortic valve opening ratio rises above 50%, the pump speed is increased by 100 revolutions per minute (RPM). As the aortic valve remains closed the RPM is lowered by 100. Speed increment is not greater than 100 RPM per 45 seconds to enable an echocardiographic analysis of resulting changes and prevent suction events. There is no determined target speed, neither per time period nor maximal.</description>
    <arm_group_label>LVAD pump speed dynamically adjusted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with implanted cardioverter-defibrillator and third-generation centrifugal&#xD;
             CF-LVAD with hydrodynamic bearing (HVAD, Medtronic, Minnesota, United States), at&#xD;
             least three months after surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemodynamic instability.&#xD;
&#xD;
          -  Non-therapeutic anticoagulation.&#xD;
&#xD;
          -  Device or intracardiac thrombus.&#xD;
&#xD;
          -  Inflammation.&#xD;
&#xD;
          -  Active bleeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maciej Stapor, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Interventional Cardiology, John Paul II Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karol Wierzbicki, Assoc Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>John Paul II Hospital</name>
      <address>
        <city>Krakow</city>
        <state>Lesser Poland</state>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 16, 2021</study_first_submitted>
  <study_first_submitted_qc>September 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>John Paul II Hospital, Krakow</investigator_affiliation>
    <investigator_full_name>Karol Wierzbicki</investigator_full_name>
    <investigator_title>Head of Cardiac Transplantation and Mechanical Circulatory Support Unit</investigator_title>
  </responsible_party>
  <keyword>left ventricular assist device</keyword>
  <keyword>cardiopulmonary exercise test</keyword>
  <keyword>stress echocardiography</keyword>
  <keyword>heart failure</keyword>
  <keyword>mechanical circulatory support</keyword>
  <keyword>peak VO2</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

